Evolution of Multitarget Strategies for Alzheimer’s Disease: From Cholinergic Inhibition to Network-Oriented Therapeutic Design (2006–2025)
Date Issued
2026-06
Author(s) USM
Soto, M.
DOI
10.3390/ph19071024
Abstract
Background: Alzheimers disease (AD) is a complex neurodegenerative disorder and a major global health challenge. The traditional one drug-one target paradigm has shown limitations in addressing its multifactorial nature. Multitarget-directed ligands (MTDL
Política de Privacidad 
